Measuring transparency to improve good governance in the public pharmaceutical sector
Oman
This report presents the findings of the first phase of the national
Good Governance for Medicines programme. In recent years, countries
of the WHO Eastern Mediterranean Region have made significant
achievements in the provision of health services. In the pharmaceutical
field, countries have been striving to improve the structures and
regulations pertaining to medicines and have progressed in many ways.
However, there are still important challenges. The goal of the WHO
Good Governance for Medicines programme is to improve the situation
of medicines regulation and supply. National transparency assessment
is the beginning of a process aimed at bringing about desirable and
sustainable changes in the governance of the pharmaceutical sector.